Real-Time PCR (qPCR) Market Research Report Information By Product (Reagents & Consumables, Instruments, Software & Services), By Application (Clinical, Research, and Forensics), By End User (Hospitals &Diagnostic Centers, Research Laboratories & Academic Institutes, Pharmaceutical & Biotechnology Companies, Clinical Research Organizations, and Forensic Laboratories), and By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2032

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.4.1. Primary Interviews and Information Gathering Process

3.4.2. Breakdown of Primary Respondents

3.5. Forecasting Techniques

3.6. Market Size Estimation

3.6.1. Bottom-Up Approach

3.6.2. Top-Down Approach

3.7. Data Triangulation

3.8. Validation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Porter’s Five Forces Analysis

5.1.1. Bargaining Power of Suppliers

5.1.2. Bargaining Power of Buyers

5.1.3. Threat of New Entrants

5.1.4. Threat of Substitutes

5.1.5. Intensity of Rivalry

5.2. Value Chain Analysis

5.3. COVID-19 Impact Analysis

5.3.1. Market Impact Analysis

5.3.2. Impact on Supply Chain

5.3.3. Regional Impact

5.3.4. Opportunity and Threat Analysis

6. GLOBAL REAL-TIME PCR (QPCR) MARKET, BY PRODUCT

6.1. Overview

6.2. Reagents & Consumables

Market Estimates & Forecast, by Region, 2018–2027

Market Estimates & Forecast, by Country, 2018–2027

6.3. Instruments

Market Estimates & Forecast, by Region, 2018–2027

Market Estimates & Forecast, by Country, 2018–2027

6.4. Software & Services

Market Estimates & Forecast, by Region, 2018–2027

Market Estimates & Forecast, by Country, 2018–2027

7. GLOBAL REAL-TIME PCR (QPCR) MARKET, BY APPLICATION

7.1. Overview

7.2. Clinical

Market Estimates & Forecast, by Region, 2018–2027

Market Estimates & Forecast, by Country, 2018–2027

7.3. Research

Market Estimates & Forecast, by Region, 2018–2027

Market Estimates & Forecast, by Country, 2018–2027

7.4. Forensics

Market Estimates & Forecast, by Region, 2018–2027

Market Estimates & Forecast, by Country, 2018–2027

7.5. Others

Market Estimates & Forecast, by Region, 2018–2027

Market Estimates & Forecast, by Country, 2018–2027

8. GLOBAL REAL-TIME PCR (QPCR) MARKET, BY END USER

8.1. Overview

8.2. Hospitals and Diagnostic Centers

Market Estimates & Forecast, by Region, 2018–2027

Market Estimates & Forecast, by Country, 2018–2027

8.3. Research Laboratories and Academic Institutes

Market Estimates & Forecast, by Region, 2018–2027

Market Estimates & Forecast, by Country, 2018–2027

8.4. Pharmaceutical and Biotechnology Companies

Market Estimates & Forecast, by Region, 2018–2027

Market Estimates & Forecast, by Country, 2018–2027

8.5. Others

Market Estimates & Forecast, by Region, 2018–2027

Market Estimates & Forecast, by Country, 2018–2027

9. GLOBAL REAL-TIME PCR (QPCR) MARKET, BY REGION

9.1. Overview

9.2. North America

9.2.1. US

9.2.2. Canada

9.3. Europe

9.3.1. Germany

9.3.2. France

9.3.3. Italy

9.3.4. Spain

9.3.5. UK

9.3.6. Rest of Europe

9.4. Asia-Pacific

9.4.1. Japan

9.4.2. China

9.4.3. India

9.4.4. Australia

9.4.5. South Korea

9.4.6. Rest of Asia-Pacific

9.5. Rest of the World

9.5.1. Middle East

9.5.2. Africa

9.5.3. Latin America

10. COMPANY LANDSCAPE

10.1. Overview

10.2. Competitive Analysis

10.3. Market Share Analysis

10.4. Major Growth Strategy in the Global Real-Time PCR (qPCR) Market

10.5. Competitive Benchmarking

10.6. Leading Players in Terms of Number of Developments in the Global Real-Time PCR (qPCR) Market

10.7. Key Developments and Growth Strategies

10.7.1. New Product Launch/Service Deployment

10.7.2. Merger &Acquisitions

10.7.3. Joint Ventures

10.8. Major Players Financial Matrix

10.8.1. Sales & Operating Income,2020

10.8.2. Major Players R&D Expenditure,2020

11. COMPANY PROFILES

11.1. ABL SA Group

11.1.1. Company Overview

11.1.2. Products Offered

11.1.3. Financial Overview

11.1.4. Key Developments

11.1.5. SWOT Analysis

11.1.6. Key Strategies

11.2. Agilent Technologies Inc

11.2.1. Company Overview

11.2.2. Products Offered

11.2.3. Financial Overview

11.2.4. Key Developments

11.2.5. SWOT Analysis

11.2.6. Key Strategies

11.3. Analytik Jena AG

11.3.1. Company Overview

11.3.2. Products Offered

11.3.3. Financial Overview

11.3.4. Key Developments

11.3.5. SWOT Analysis

11.3.6. Key Strategies

11.4. BD

11.4.1. Company Overview

11.4.2. Products Offered

11.4.3. Financial Overview

11.4.4. Key Developments

11.4.5. SWOT Analysis

11.4.6. Key Strategies

11.5. Bio-Rad Laboratories

11.5.1. Company Overview

11.5.2. Products Offered

11.5.3. Financial Overview

11.5.4. Key Developments

11.5.5. SWOT Analysis

11.5.6. Key Strategies

11.6. F-Hoffman-La Roche Ltd.

11.6.1. Company Overview

11.6.2. Products Offered

11.6.3. Financial Overview

11.6.4. Key Developments

11.6.5. SWOT Analysis

11.6.6. Key Strategies

11.7. Fluidigm Corporation

11.7.1. Company Overview

11.7.2. Products Offered

11.7.3. Financial Overview

11.7.4. Key Developments

11.7.5. SWOT Analysis

11.7.6. Key Strategies

11.8. Lumex Instruments

11.8.1. Company Overview

11.8.2. Products Offered

11.8.3. Financial Overview

11.8.4. Key Developments

11.8.5. SWOT Analysis

11.8.6. Key Strategies

11.9. Primerdesign Ltd.

11.9.1. Company Overview

11.9.2. Products Offered

11.9.3. Financial Overview

11.9.4. Key Developments

11.9.5. SWOT Analysis

11.9.6. Key Strategies

11.10. Qiagen

11.10.1. Company Overview

11.10.2. Products Offered

11.10.3. Financial Overview

11.10.4. Key Developments

11.10.5. SWOT Analysis

11.10.6. Key Strategies

11.11. ThermoFisher Scientific

11.11.1. Company Overview

11.11.2. Products Offered

11.11.3. Financial Overview

11.11.4. Key Developments

11.11.5. SWOT Analysis

11.11.6. Key Strategies

11.12. Takara Bio Inc.

11.12.1. Company Overview

11.12.2. Products Offered

11.12.3. Financial Overview

11.12.4. Key Developments

11.12.5. SWOT Analysis

11.12.6. Key Strategies

11.13. Toyobo Inc.

11.13.1. Company Overview

11.13.2. Products Offered

11.13.3. Financial Overview

11.13.4. Key Developments

11.13.5. SWOT Analysis

11.13.6. Key Strategies

11.14. Vela Diagnostics

11.14.1. Company Overview

11.14.2. Products Offered

11.14.3. Financial Overview

11.14.4. Key Developments

11.14.5. SWOT Analysis

11.14.6. Key Strategies

12. APPENDIX

12.1. References

12.2. Related Reports

LIST OF TABLES

TABLE 1 GLOBAL REAL-TIME PCR (QPCR) MARKET SYNOPSIS, 2018–2027

TABLE 2 GLOBAL REAL-TIME PCR (QPCR)MARKET ESTIMATES &FORECAST, 2018–2027 (USD MILLION)

TABLE 3 GLOBAL REAL-TIME PCR (QPCR) MARKET, BYPRODUCT, 2018–2027 (USD MILLION)

TABLE 4 GLOBAL REAL-TIME PCR (QPCR) MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 5 NORTH AMERICA: REAL-TIME PCR (QPCR) MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 6 NORTH AMERICA REAL-TIME PCR (QPCR) MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 7 US: REAL-TIME PCR (QPCR) MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 8 US REAL-TIME PCR (QPCR) MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 9 CANADA: REAL-TIME PCR (QPCR) MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 10 CANADA REAL-TIME PCR (QPCR) MARKET, BY APPLICATION, 2017–2027 (USD MILLION)

TABLE 11 EUROPE: REAL-TIME PCR (QPCR) MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 12 EUROPE: REAL-TIME PCR (QPCR) MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 13 GERMANY: REAL-TIME PCR (QPCR) MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 14 GERMANY: REAL-TIME PCR (QPCR) MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 15 UK: REAL-TIME PCR (QPCR) MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 16 UK: REAL-TIME PCR (QPCR) MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 17 FRANCE: REAL-TIME PCR (QPCR) MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 18 FRANCE: REAL-TIME PCR (QPCR) MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 19 ITALY: REAL-TIME PCR (QPCR) MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 20 ITALY: REAL-TIME PCR (QPCR) MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 21 SPAIN: REAL-TIME PCR (QPCR) MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 22 SPAIN: REAL-TIME PCR (QPCR) MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 23 REST OF EUROPE: REAL-TIME PCR (QPCR) MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 24 REST OF EUROPE: REAL-TIME PCR (QPCR) MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 25 ASIA-PACIFIC: REAL-TIME PCR (QPCR) MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 26 ASIA-PACIFIC: REAL-TIME PCR (QPCR) MARKET, BY APPLICATION,2018–2027 (USD MILLION)

TABLE 27 INDIA: REAL-TIME PCR (QPCR) MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 28 INDIA: REAL-TIME PCR (QPCR) MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 29 CHINA: REAL-TIME PCR (QPCR) MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 30 CHINA: REAL-TIME PCR (QPCR) MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 31 JAPAN: REAL-TIME PCR (QPCR) MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 32 JAPAN: REAL-TIME PCR (QPCR) MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 33 AUSTRALIA: REAL-TIME PCR (QPCR) MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 34 AUSTRALIA: REAL-TIME PCR (QPCR) MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 35 SOUTH KOREA: REAL-TIME PCR (QPCR) MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 36 SOUTH KOREA: REAL-TIME PCR (QPCR) MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 37 REST OF ASIA-PACIFIC: REAL-TIME PCR (QPCR)MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 38 REST OF ASIA-PACIFIC: REAL-TIME PCR (QPCR)MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 39 REST OF THE WORLD: REAL-TIME PCR (QPCR) MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 40 REST OF THE WORLD: REAL-TIME PCR (QPCR)MARKET, APPLICATION, 2018–2027 (USD MILLION)

TABLE 41 MIDDLE EAST: REAL-TIME PCR (QPCR) MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 42 MIDDLE EAST: REAL-TIME PCR (QPCR)MARKET, APPLICATION, 2018–2027 (USD MILLION)

TABLE 43 AFRICA: REAL-TIME PCR (QPCR)MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 44 AFRICA: REAL-TIME PCR (QPCR)MARKET, APPLICATION,2018–2027 (USD MILLION)

TABLE 45 LATIN AMERICA: REAL-TIME PCR (QPCR)MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 46 LATIN AMERICA: REAL-TIME PCR (QPCR)MARKET, APPLICATION, 2018–2027 (USD MILLION)

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL REAL-TIME PCR (QPCR) MARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL REAL-TIME PCR (QPCR) MARKET

FIGURE 4 GLOBAL REAL-TIME PCR (QPCR) MARKET SHARE, BY PRODUCT, 2020(%)

FIGURE 5 GLOBAL REAL-TIME PCR (QPCR)MARKET SHARE, BY APPLICATION, 2020(%)

FIGURE 6 GLOBAL REAL-TIME PCR (QPCR) MARKET SHARE, BY REGION, 2020(%)

FIGURE 7 NORTH AMERICA: REAL-TIME PCR (QPCR)MARKET SHARE, BY REGION, 2020 (%)

FIGURE 8 EUROPE: REAL-TIME PCR (QPCR) MARKET SHARE, BY REGION, 2020(%)

FIGURE 9 ASIA-PACIFIC: REAL-TIME PCR (QPCR) MARKET SHARE, BY REGION, 2020(%)

FIGURE 10 REST OF THE WORLD: REAL-TIME PCR (QPCR) MARKET SHARE, BY REGION, 2020(%)

FIGURE 11 GLOBAL REAL-TIME PCR (QPCR) MARKET: COMPANY SHARE ANALYSIS, 2020(%)

FIGURE 12 ABL SA GROUP: KEY FINANCIALS

FIGURE 13 ABL SA GROUP: SWOT ANALYSIS

FIGURE 14 AGILENT TECHNOLOGIES, INC: KEY FINANCIALS

FIGURE 15 AGILENT TECHNOLOGIES, INC:SWOT ANALYSIS

FIGURE 16 ANALYTIK JENA AG: KEY FINANCIALS

FIGURE 17 ANALYTIK JENA AG: SWOT ANALYSIS

FIGURE 18 BD: KEY FINANCIALS

FIGURE 19 BD: SWOT ANALYSIS

FIGURE 20 BIO-RAD LABORATORIES, INC.: KEY FINANCIALS

FIGURE 21 BIO-RAD LABORATORIES, INC.: SWOT ANALYSIS

FIGURE 22 F. HOFFMANN-LA ROCHE LTD: KEY FINANCIALS

FIGURE 23 F. HOFFMANN-LA ROCHE LTD: SWOT ANALYSIS

FIGURE 24 FLUIDIGM CORPORATION: KEY FINANCIALS

FIGURE 25 FLUIDIGM CORPORATIONSWOT ANALYSIS

FIGURE 26 LUMEX INSTRUMENTS: KEY FINANCIALS

FIGURE 27 LUMEX INSTRUMENTS: SWOT ANALYSIS

FIGURE 28 PRIMERDESIGN LTD: KEY FINANCIALS

FIGURE 29 PRIMERDESIGN LTD: SWOT ANALYSIS

FIGURE 30 QIAGEN: KEY FINANCIALS

FIGURE 31 QIAGEN: SWOT ANALYSIS

FIGURE 32 TAKARA BIO INC: KEY FINANCIALS

FIGURE 33 TAKARA BIO INC: SWOT ANALYSIS

FIGURE 34 THERMO FISHER SCIENTIFIC: KEY FINANCIALS

FIGURE 35 THERMO FISHER SCIENTIFIC: SWOT ANALYSIS

FIGURE 36 TOYOBO INC: KEY FINANCIALS

FIGURE 37 TOYOBO INC: SWOT ANALYSIS

FIGURE 38 VELA DIAGNOSTICS: KEY FINANCIALS

FIGURE 39 VELA DIAGNOSTICS: SWOT ANALYSIS